Active Ingredient: SOLIFENACIN SUCCINATE
Proprietary Name: SOLIFENACIN SUCCINATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A204374
Product Number: 002
Approval Date: Feb 20, 2024
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information